Efficacy and Safety of Venetoclax Plus Azacitidine for Patients With Treatment-Naive High-Risk Myelodysplastic Syndromes.
Garcia JS, Platzbecker U, Odenike O, Fleming SA, Fong CY, Borate U, Jacoby MA, Nowak D, Baer MR, Peterlin P, Chyla B, Wang H, Ku G, Hoffman D, Potluri J, Garcia-Manero G.
Garcia JS, et al. Among authors: fleming sa.
Blood. 2024 Dec 9:blood.2024025464. doi: 10.1182/blood.2024025464. Online ahead of print.
Blood. 2024.
PMID: 39652823
Free article.